© 2024 Syngene International Limited. All rights reserved
Why Syngene
Full-scale, integrated CDMO
30 years of experience and 400+ active global clients
Wide industry experience
Across pharma, biotech, nutrition, animal health, consumer goods and speciality chemical companies
Expert, multi-disciplinary team
6000+ scientists and 400+ patent credits
Full, value-chain capabilities in one campus
Supply chain, procurement, logistics, delivery, technology transfer and regulatory
International accreditations
US FDA, EMA and PMDA approved; GLP, GMP, ISO certified; AAALAC, ANVISA accredited facilities
Regulatory experience
Across IND and IMPD dossier preparation for regulatory approvals
Flexible and varied business models
Stand-alone services and defined, integrated activity bundles
Continuous process improvement
For increased productivity and faster turn-around time
DCAT week is a much-anticipated event every year offering opportunities to both biopharma companies and CRO/CDMOs to network, learn and grow together.
As a leading CRO/CDMO, Syngene offers integrated, end-to-end development and manufacturing services from one campus to easily advance clinical candidates from Preclinical to NDA filing. Our high-end capabilities extend across the Development lifecycle spanning Process R&D, Formulation Development (including Clinical Supplies), Analytical Development, Clinical Development, and API commercial manufacturing (70,000L capacity).
In biologics, we have expertise in recombinant proteins, glycoproteins, mAbs, antibody fragments, bispecifics, and microbiome (live biotherapeutics).
We have an installed biologics drug substance manufacturing capacity of 28,000L. We also offer a commercial-scale, high-speed, sterile Fill-Finish facility for small molecules and biologics.
Meet our experts
Jonathan Hunt
Chief Executive Officer & Managing Director
Alex Del Priore
Sr. Vice President – Manufacturing Services
Ian Grundy
Head of Sales, Development & Manufacturing Services
Nageswara Rao
VP Business Development, Clinical Development services
Simon Hickling
VP Business Development, Development & Manufacturing Services, NA
Manoj Babu
VP Business Development, Development & Manufacturing Services, NA
Jeffrey Wong
Head of Sales, Biologics
Pravin Prajapati
Director, Business Development, Biologics
Insights and Resources
Small Molecule Development and Manufacturing
Syngene offers chemical development, formulation, analytical, clinical development, and manufacturing services across small molecules, oligonucleotides, HPAPIs, and performance and specialty materials.
Biologics Development and Manufacturing
Syngene offers end-to-end Biologics Development and Manufacturing solutions for mammalian and microbial systems, including Viral Testing and Sterile Fill-Finish. We also have the expertise to move from Gene to GMP in 10 months.
Clinical Development
Syngene offers BA/BE studies for generic drugs, clinical trial management (Phase1-3), central laboratory services, regulated bioanalytical lab services, clinical data management, and biometric services.
Animal Health
Syngene offers comprehensive Animal Healthcare services across the drug discovery, development, and manufacturing continuum for small molecules and biologics.